{"id":"W4408157999","doi":"10.1186/s40164-025-00610-1","title":"Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Oncology; Follicular phase; Internal medicine; Lymphoma; Second line; First line; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002052083,0.0001828078,0.001139723,0.000132849,0.0001046838,0.000002713855,0.00007054265,0.0002811099,0.0001786266],"category_scores_gemma":[0.00003467912,0.0001060102,0.0000770129,0.0001248783,0.0006554743,0.00002345683,0.00007287136,0.00008297816,2.969969e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001302715,"about_ca_system_score_gemma":0.0001840478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001037992,"about_ca_topic_score_gemma":0.000112457,"domain_scores_codex":[0.9987007,0.0001638763,0.0005561208,0.0002738678,0.00009759803,0.0002078249],"domain_scores_gemma":[0.9979432,0.001508969,0.0001954527,0.0002354941,0.00005427351,0.00006267532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2292985,0.01177641,0.04055369,0.001556093,0.003567648,0.0001770261,0.02879835,0.000007913149,0.5630775,0.002810799,0.0007450223,0.117631],"study_design_scores_gemma":[0.03306128,0.02074187,0.01791959,0.0001623651,0.0003754158,0.0003520799,0.005311446,0.0004244722,0.9110278,0.00006761924,0.01042514,0.0001308784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724488,0.02538556,0.00004516437,0.0004235381,0.0001130545,0.001284757,0.00001724606,0.00001257978,0.0002692855],"genre_scores_gemma":[0.9949213,0.002298283,0.0008154823,0.00008536074,0.00001890552,0.0001045091,0.00002047354,0.00001536743,0.001720358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3479503,"threshold_uncertainty_score":0.4322969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05139039836616287,"score_gpt":0.3986450694704503,"score_spread":0.3472546711042874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}